Background context: Minimally invasive lateral lumbar interbody fusion (MIS-LLIF) and transforaminal lumbar interbody fusion (TLIF) are widely used for lumbar degenerative disease. However, their comparative risk for adjacent segment disease (ASD) remains controversial. Changes in segmental lordosis (∆SL) may play a mediating role in ASD development, but this pathway has not been rigorously quantified.
Purpose: This study aimed to compare the risk of ASD following MIS-LLIF versus TLIF and to evaluate whether ∆SL mediates this relationship.
Study design/setting: An exploratory retrospective cohort study of patients who underwent single-level lumbar fusion at a single institution.
Patient sample: We reviewed 143 patients who underwent single-level MIS-LLIF or TLIF between January 2017 and December 2022.
Outcome measures: The primary outcome measure was the incidence of radiographically confirmed ASD with a minimum 2-year follow-up. The mediating variable was the change in segmental lordosis (∆SL).
Methods: Baseline demographics, surgical parameters, and radiographic outcomes were collected. The mediating effect of ∆SL was assessed using Baron and Kenny with Sobel testing, adjusting for covariates. A counterfactual-based mediation analysis with bootstrap confidence intervals (1,000 samples) was also performed to validate the findings.
Results: The overall incidence of ASD was 16.1% (23.2% in MIS-LLIF vs. 9.5% in TLIF; P=0.045). MIS-LLIF resulted in less segmental lordosis improvement (∆SL) than TLIF (1.50° vs. 2.60°; P<0.001). Initially, MIS-LLIF was associated with higher ASD odds (OR 2.78, 95% CI: 1.12-7.45; P =0.027). Mediation analysis (α = 0.10) identified ∆SL as a mediator, accounting for 64.6% of the total effect (indirect effect: 0.083, 95% CI: 0.01-0.20, P=0.028). After adjusting for ∆SL, the surgical approach was no longer significantly associated with ASD (OR 1.78, 95% CI: 0.56-5.95; P=0.300), whereas ∆SL remained an independent protective factor (OR 0.53 per degree, 95% CI: 0.31-0.87; P=0.010).
Conclusions: In this exploratory analysis, ∆SL statistically explained a substantial proportion of the association between surgical approach and ASD risk. Optimizing segmental lordosis restoration may be a critical and modifiable factor for mitigating ASD, warranting prospective validation.
Background context: The migration of spine surgery to ambulatory surgical centers (ASCs) continues to expand, but national trends in the utilization and cost of anterior cervical discectomy and fusion (ACDF) in these settings remain understudied. This study evaluates trends in volume, payer mix, and inflation-adjusted charges for single-level ACDF procedures performed in hospital-owned ASCs across the United States.
Purpose: To characterize national trends in the utilization and inflation-adjusted cost of single-level ACDF procedures performed in hospital-owned ASCs from 2016 to 2022.
Design: Retrospective cross-sectional study PATIENT SAMPLE: Adult patients undergoing single-level ACDF procedures at ASCs from the National Ambulatory Surgery Sample (NASS) database OUTCOME MEASURES: Our outcomes included outpatient procedure volumes, patient and facility demographics, and payer composition stratified by region and season.
Methods: We conducted a retrospective cross-sectional analysis of the NASS database from 2016 to 2022, identifying single-level ACDF procedures using CPT code 22551. Adult patients undergoing outpatient surgery were included. Survey-weighted methods were used to generate national estimates. Generalized linear models assessed differences in inflation-adjusted per-procedure charges by payer, geographic region, and season. Volume and market share trends were evaluated using linear regression.
Results: A total of 399,939 weighted single-level ACDF procedures were identified. Case volume increased from 33,687 in 2016 to 73,024 in 2021, with a slight decline in 2022. Median patient age increased from 52 to 57 years. The share of Medicare patients grew from 8.6% to 29%, while private insurance declined from 74% to 53%. The overall geometric mean cost was $57,600. Charges varied significantly by payer (P < 0.001), region (P < 0.001), and season (P < 0.001). Procedures in the West were 41% more expensive than in the Northeast. Medicare exhibited the fastest growth in both volume and cost.
Conclusion: ASC-based ACDF procedures have increased substantially, with increasing median patient age, Medicare relative to private patients, and regional cost variation. These findings have important implications for surgical planning, reimbursement, and policy development.
Level of evidence: III.

